391.1000 -5.30 (-1.34%)
NSE Apr 02, 2026 15:31 PM
Volume: 535.8K
 

391.10
-1.34%
Angel Broking
Unique investment opportunity in drug research business: While almost all Indian pharma companies are in generic drugs business, Syngene supports its clients to invent new drugs. It has 8 of the top 10 global pharma companies as its clients and also has long term contracts with some big pharma companies. In our view Syngene provides a uni..
Syngene International Ltd. is trading below all available SMAs
More from Syngene International Ltd.
Recommended